Literature DB >> 1360668

Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein.

K Q Hu1, C H Yu, J M Vierling.   

Abstract

Intercellular adhesion molecule 1 (ICAM-1), a counter-receptor for lymphocyte function-associated antigen 1 on T cells, is critically important to a wide variety of adhesion-dependent leukocyte functions, including antigen presentation and target cell lysis. ICAM-1 expression by hepatocytes is increased in areas of inflammation and necrosis during chronic hepatitis B. Whether induction of ICAM-1 is due to the effect of inflammatory cytokines or involves a direct effect of the hepatitis B virus (HBV) remains unknown. In the present study, transfection of the HBV genome into human hepatoma cell lines resulted in enhanced expression of ICAM-1 protein and RNA in the absence of inflammation. Results of subgenomic transfections indicated that the HBV X protein (pX) induced ICAM-1 expression. Nuclear run-on assays showed that pX induced the ICAM-1 gene by increasing its rate of transcription. Although both pX and interferon gamma induced transcription of ICAM-1, addition of interferon gamma to cells expressing pX did not show an additive or synergistic effect. These results indicate that pX can directly regulate expression of ICAM-1 and may participate in the immunopathogenesis of HBV infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360668      PMCID: PMC50567          DOI: 10.1073/pnas.89.23.11441

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.

Authors:  D L Mueller; M K Jenkins; R H Schwartz
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Transcriptional trans-activating function of hepatitis B virus.

Authors:  J S Twu; R H Schloemer
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

3.  trans-activation of viral enhancers by the hepatitis B virus X protein.

Authors:  D F Spandau; C H Lee
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  A simplification of the nuclear run-off transcription assay.

Authors:  P Celano; C Berchtold; R A Casero
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

5.  The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase.

Authors:  J Y Wu; Z Y Zhou; A Judd; C A Cartwright; W S Robinson
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

6.  Intrahepatic expression of pre-S proteins of hepatitis B virus and its possible relation to liver cell necrosis.

Authors:  K Q Hu; L J Hao; Y Y Zhang; Y K Wang
Journal:  Am J Gastroenterol       Date:  1989-12       Impact factor: 10.864

7.  trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein.

Authors:  A Siddiqui; R Gaynor; A Srinivasan; J Mapoles; R W Farr
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

Review 8.  The hepatitis B virus.

Authors:  P Tiollais; C Pourcel; A Dejean
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

9.  Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.

Authors:  J S Twu; K Chu; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells.

Authors:  M L Dustin; T A Springer
Journal:  J Cell Biol       Date:  1988-07       Impact factor: 10.539

View more
  13 in total

1.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

Authors:  S Stoll-Becker; R Repp; D Glebe; S Schaefer; J Kreuder; M Kann; F Lampert; W H Gerlich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Effects of cytokines on the binding of leukocytes to cultured rat hepatocytes and on the expression of ICAM-1 by hepatocytes.

Authors:  K Sano; M Nagaki; A Sugiyama; H Hatakeyama; H Ohnishi; Y Muto; H Moriwaki
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

3.  The X protein of hepatitis B virus coactivates potent activation domains.

Authors:  I Haviv; D Vaizel; Y Shaul
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

4.  Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia.

Authors:  K D Newman; P F Dunn; J W Owens; A H Schulick; R Virmani; G Sukhova; P Libby; D A Dichek
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis.

Authors:  G Kaplanski; C Farnarier; M J Payan; P Bongrand; J M Durand
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

6.  Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.

Authors:  P L Majano; C García-Monzón; M López-Cabrera; E Lara-Pezzi; E Fernández-Ruiz; C García-Iglesias; M J Borque; R Moreno-Otero
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

7.  A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.

Authors:  V Kumar; N Jayasuryan; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 8.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

9.  Hepatitis B virus transactivator protein X interacts with the TATA-binding protein.

Authors:  I Qadri; H F Maguire; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology].

Authors:  M A Kern; K Breuhahn; M Schuchmann; P Schirmacher
Journal:  Pathologe       Date:  2007-07       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.